Bird & Bird advised Materia on its acquisition of German licensed medicinal cannabis distributor Cannaktiv

Bird & Bird LLP advised Materia on the acquisition of all shares in German licensed medicinal cannabis distributor Cannaktiv GmbH. The deal provides Materia – an international manufacturer and distributor of medicinal cannabis with worldwide operations – with access to the German market.

Cannaktiv is a licensed importer and distributor of medicinal cannabis products in Germany, based in Hamburg. Bird & Bird advised Materia on the whole acquisition process including the due diligence, all regulatory and license related matters as well as the framework for market access of medicinal cannabis products and related communications.

Materia is a medicinal cannabis and wellness company primarily in the European market. It is the company's vision to be a provider of global access to medicinal cannabis. Materia mainly focusses on the extraction of cannabis to ensure that patients have access to pure, tested and highly efficient extract medicines, on the import of low-cost biomass from its international partners and having EU GMP facilities throughout Europe. These will provide it with an early mover advantage to access the European market. In order to achieve this purpose, Materia is developing a robust manufacturing and distribution ecosystem to grow the legal cannabis market across the European continent.

Cannaktiv, based in Hamburg, fits perfectly with Materia’s strategy as it is active in the business of import, trade and distribution of cannabis for medicinal purposes. Cannaktiv holds all requisite licenses to import and distribute medical cannabis products to wholesalers and pharmacies throughout Germany. The acquisition of Cannaktiv therefore will expand Materia’s distribution capabilities into Europe’s largest medical cannabis market.

Materia will operate Cannaktiv as Materia Deutschland GmbH, engaging prescribers of medical cannabis and selling to pharmacies and wholesalers.

Materia Ventures was advised by the following Bird & Bird team: partners Dr. Kai Kerger (Corporate/M&A) and Dr. Niels Lutzhöft (Commercial/Regulatory) and associate Johanna Schindler (Corporate/M&A), as well as partners Dr. Barbara Geck (Employment) and Mascha Grundmann (IP), associates Dr. Christoph Hendel, Dr. Simon Hembt (both Commercial/Regulatory), Franziska Fiedler (Employment), Julia Präger (IP), Johannes Wirtz, LL.M. and Timo Förster (both Finance), all Frankfurt.

News & Deals

More News & Deals

Deal

Bird & Bird advises shareholders of 2i Limited on an eight-figure investment by Rockpool Investments

May 09 2024

Read More

Deal

Bird & Bird advises Radio Frequency Systems on the sale of its global cable business to Yangtze Optical Fibre and Cable Joint Stock

May 07 2024

Read More

Deal

Bird & Bird advised Hitachi Energy in Finland on €170 million development project regarding new production and technology campus

May 02 2024

Read More

News

Bird & Bird appoints 13 to Partner, 3 to Senior Counsel, 24 to Counsel, 1 to Legal Director and 1 to Of Counsel in annual global promotion round

May 01 2024

Read More

Deal

Bird & Bird advises BRIDOR on its acquisition of the PANDRIKS Group

Apr 30 2024

Read More

News

Bird & Bird France wins Ishka: Aviation Finance Best Supported Financing Deal of the Year Award 2023

Apr 29 2024

Read More